United States· US:23594-150_414d62f1-85aa-cfa6-e063-6394a90a69fc
EXXUA
A gepirone product containing gepirone hydrochloride, registered in United States by Aytu Therapeutics, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GEPIRONE HYDROCHLORIDE
- Manufacturer
- Aytu Therapeutics, LLC
- Country
- United States (US)
- ATC code
- N06AX19
- ATC class
- Gepirone
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 12, 2026
Packs & prices · 4
- ndc1123594-150-30
- ndc1123594-150-32
- ndc11235941503030 TABLET, EXTENDED RELEASE in 1 BOTTLE (23594-150-30)
- ndc11235941503232 TABLET, EXTENDED RELEASE in 1 BOTTLE (23594-150-32)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N06AX19
Gepirone, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c368390d-ea95-4e01-813b-9adeab06f734 GET /v1/drugs/c368390d-ea95-4e01-813b-9adeab06f734?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "18.2",
"substance": "GEPIRONE HYDROCHLORIDE",
"productndc": "23594-150",
"dosage_form": "TABLET, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA021164",
"marketing_category": "NDA"
}See everything about gepirone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.